122 related articles for article (PubMed ID: 20502053)
1. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
Abreu AP; Kaiser UB; Latronico AC
Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
[TBL] [Abstract][Full Text] [Related]
2. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
[TBL] [Abstract][Full Text] [Related]
3. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract][Full Text] [Related]
4. Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases.
Cheng XX; Li MQ; Peng T
Int J Med Sci; 2024; 21(1):27-36. PubMed ID: 38164347
[TBL] [Abstract][Full Text] [Related]
5. The prokineticins: a novel pair of regulatory peptides.
Zhou QY
Mol Interv; 2006 Dec; 6(6):330-8. PubMed ID: 17200460
[TBL] [Abstract][Full Text] [Related]
6. Effects of Prokineticins on Cerebral Cell Function and Blood-Brain Barrier Permeability.
Younes H; Kyritsi I; Mahrougui Z; Benharouga M; Alfaidy N; Marquette C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895111
[TBL] [Abstract][Full Text] [Related]
7. Prokineticin signaling in heart-brain developmental axis: Therapeutic options for heart and brain injuries.
Désaubry L; Kanthasamy AG; Nebigil CG
Pharmacol Res; 2020 Oct; 160():105190. PubMed ID: 32937177
[TBL] [Abstract][Full Text] [Related]
8. PROK2-PROKR2 Signaling: New Contributor to Pleasant Touch.
Chen FL; Yin HY; Tang Y
Neurosci Bull; 2023 Feb; 39(2):356-358. PubMed ID: 35960443
[No Abstract] [Full Text] [Related]
9. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.
Nykamp K; Anderson M; Powers M; Garcia J; Herrera B; Ho YY; Kobayashi Y; Patil N; Thusberg J; Westbrook M; ; Topper S
Genet Med; 2017 Oct; 19(10):1105-1117. PubMed ID: 28492532
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
Martinez-Mayer J; Perez-Millan MI
Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
[TBL] [Abstract][Full Text] [Related]
11. Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency.
Cox KH; Oliveira LMB; Plummer L; Corbin B; Gardella T; Balasubramanian R; Crowley WF
Hum Mol Genet; 2018 Jan; 27(2):338-350. PubMed ID: 29161432
[TBL] [Abstract][Full Text] [Related]
12. PROK2/PROKR2 Signaling and Kallmann Syndrome.
Dodé C; Rondard P
Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
[TBL] [Abstract][Full Text] [Related]
13. Expression of PROKR1 and PROKR2 in human enteric neural precursor cells and identification of sequence variants suggest a role in HSCR.
Ruiz-Ferrer M; Torroglosa A; Núñez-Torres R; de Agustín JC; Antiñolo G; Borrego S
PLoS One; 2011; 6(8):e23475. PubMed ID: 21858136
[TBL] [Abstract][Full Text] [Related]
14. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
Martin C; Balasubramanian R; Dwyer AA; Au MG; Sidis Y; Kaiser UB; Seminara SB; Pitteloud N; Zhou QY; Crowley WF
Endocr Rev; 2011 Apr; 32(2):225-46. PubMed ID: 21037178
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
Vincenzi M; Kremić A; Jouve A; Lattanzi R; Miele R; Benharouga M; Alfaidy N; Migrenne-Li S; Kanthasamy AG; Porcionatto M; Ferrara N; Tetko IV; Désaubry L; Nebigil CG
Pharmacol Rev; 2023 Nov; 75(6):1167-1199. PubMed ID: 37684054
[TBL] [Abstract][Full Text] [Related]
16. A functional spectrum of PROKR2 mutations identified in isolated hypogonadotropic hypogonadism.
Wang X; Chen D; Zhao Y; Men M; Chen Z; Jiang F; Zheng R; Stamou MI; Plummer L; Balasubramanian R; Li JD
Hum Mol Genet; 2023 May; 32(10):1722-1729. PubMed ID: 36694982
[TBL] [Abstract][Full Text] [Related]
17. Prokineticin-Receptor Network: Mechanisms of Regulation.
Lattanzi R; Miele R
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207461
[TBL] [Abstract][Full Text] [Related]
18. Oligogenic Inheritance Underlying Incomplete Penetrance of
Mkaouar R; Abdallah LCB; Naouali C; Lahbib S; Turki Z; Elouej S; Bouyacoub Y; Somai M; Mcelreavey K; Bashamboo A; Abdelhak S; Messaoud O
Front Genet; 2021; 12():665174. PubMed ID: 34539727
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
